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Abstract
Both selenium (Se) deficiency and excess are found in natural locations throughout the world, though Se excess can
also be caused by supplementation with Se. Both have been associated with adverse health effects that have often
been characterized by a U-shaped relationship. Some health effects, such as increased mortality, are associated with
both low and high Se status. Certain people and populations are better able to tolerate low or high Se intake than
others; there are a number of possible explanations for this fact. Firstly, it may relate to the presence of polymor-
phisms (SNPs) in genes that improve the ability to deal with a low or high Se intake. Secondly, high Se status, with
apparent absence of toxicity and even beneficial effects, can be found in populations exposed to toxic elements that
are known to interact with Se, forming complexes in some cases. Thirdly, beneficial and harmful effects of Se
depend on Se dose and form (speciation); for instance, at a high dose, selenomethionine (SeMet) has toxic effects
that are mediated by metabolism to selenols/selenolates that can redox-cycle, generate superoxide radicals and react
with thiols/diselenides to produce selenyl sulphides/disulphides. Finally, it is possible that exposure to a high Se
intake from birth or from a very young age may alter the composition of the gut microbiota in such a way that
excess Se is more readily excreted, thus reducing its toxicity.
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Introduction
The highly insightful observation made by Confucius (551 to
479 BC), “Excess and deficiency are equally at fault”, is as
relevant today as it was 2500 years ago, and it applies to almost
all nutrients, though it is particularly apposite to selenium (Se).
Se intake is extremely variable across the world [1]
owing to a number of factors, including the Se content
of the soil in which crops and fodder are grown, Se
speciation, soil pH and organic-matter content, and the
presence of ions that can complex with Se [2]. This fact
enables the effects of both Se deficiency and excess to
be observed in the natural world.
Effects of Se deficiency
Some adverse health conditions associated with Se deficiency
are listed in Table 1.
A further example that is less well known relates to the
reduction in risk of incident tuberculosis (TB) in HIV-
infected subjects who were treated with Se. Because HIV
is an immune-deficiency syndrome, those with this disease
commonly suffer from other infections, such as TB, partic-
ularly as the condition progresses [15]. In a 24-month, four-
arm, randomized, controlled trial (RCT) in 878 HIV-infected
adults in Botswana, who were randomized to Se, multivita-
mins, Se+multivitamins or placebo, treatment with 200 μg
Se+multivitamins significantly reduced the risk of immune
decline and morbidity, while multivitamins alone and Se
alone had no effect [16]. Importantly, Se vs. placebo signif-
icantly reduced the risk of incident TB: hazard ratio (HR)
0.20, 95%; confidence interval (CI): 0.04, 0.95; P = 0.043.
When the Se and Se+multivitamin arms were combined, the
risk of TB was also reduced: HR 0.32, 95% CI: 0.11, 0.93;
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P = 0.036 [15]. This is an important finding in relation to
HIV outcome, particularly in sub-Saharan Africa, where TB
can often be fatal.
Effects of Se excess
The effects of Se excess are probably less well known. Apart
from some occasional cases of overdose where people have
ingested wrongly formulated supplements [17], Se excess has
mostly been observed in RCTs, where doses of 200 μg/day or
more of Se have been given for a substantial period of time
(see Table 2).
Adverse health effects associated with,
or caused by, both Se deficiency and excess:
Se and mortality
It is of note that some health conditions are associated with
both Se deficiency and excess, i.e. increased mortality, type 2
diabetes and increased prostate cancer risk [6, 12, 13].
Increased mortality is seen at both low and high plasma Se
concentrations. This was first demonstrated by the Guallar
group at Johns Hopkins School of Public Health, Baltimore,
USA, which examined data from the US Third National
Health and Nutrition Examination Survey. Serum Se was
measured in 13,887 adult participants who were then followed
up for mortality for up to 12 years [6] and subsequently for a
further 6 years [3]. Mortality showed a U-shaped association,
reaching a minimum at a serum Se concentration of 135 μg/L.
Increased mortality was seen at the highest dose level of an
RCT of Se in the Danish PRECISE trial, a randomized, dou-
ble-blinded, placebo-controlled, clinical trial with four groups
[20]. Participants were 491 male and female volunteers aged
60–74 years who were randomly assigned to treatment with
100, 200 or 300 μg Se/day as Se-enriched yeast or placebo
yeast for 5 years from randomization in 1998–1999 and were
followed up for mortality for a further 10 years. In an
intention-to-treat analysis, the HR (95%CI) for all-cause mor-
tality comparing 300 μg Se/day with placebo was 1.62 (0.66,
3.96) after 5 years of treatment and 1.59 (1.02, 2.46) over the
entire follow-up period [20]. The relationship between cumu-
lative mortality from all causes over time by treatment group
in the Danish PRECISE RCT is shown in Fig. 1. The results of
this study warn that a 300-μg/day dose of Se (as Se yeast)
taken for 5 years in a country with moderately low Se status
can increase all-cause mortality 10 years later.
The relationship between Se intake/status and mortality is
an excellent example of the U-shaped association between Se
and health. Figure 2 illustrates that relationship, additionally
including data referred to in Tables 1 and 2 [23].
Table 2 Health risks significantly related to selenium excess
Health condition Reference
Selenosis (Se toxicity) [2, 17]
Alopecia (seen in SELECT) [18]
Dermatitis (seen in SELECT) [18]
Non-melanoma skin cancer (seen in NPC trial) [19]
Increased mortality [6] [20]
Type 2 diabetes (seen in the NPC trial) [21]
Increased prostate cancer risk (seen in SELECT) [22]
Fig. 1 Cumulative mortality from all causes over time by treatment
group. Non-parametric cumulative mortality curves (step functions) were
estimated via the Kaplan-Meier method and compared with results gen-
erated by the generalized Wilcoxon test. Parametric cumulative mortality
curves (smooth lines) were estimated from spline-based parametric sur-
vival models with treatment-specific log cumulative hazards parameter-
ized as natural cubic splines of log time with knots at the 33th and 67th
percentiles of the uncensored log-time distribution. Cumulative mortality
estimates (95%CIs) at 5, 10 and 15 years of follow-up by treatment group
were obtained from spline-based parametric survival models. Se denotes
selenium [20] (published with permission of FRBM)
Table 1 Conditions that have been associated with Se deficiency [3]
Condition Reference
Keshan disease [2]
Kashin-Beck disease [4]
Increased viral virulence [5]
Increased mortality [6]
Poorer immune function [7]
Problematic fertility/reproduction [3]
Thyroid autoimmune disease [8]
Cognitive decline/dementia [9–11]
Type 2 diabetes [12]
Prostate cancer risk [13]
Colorectal cancer risk in women (seen in EPIC) [14]
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Complexities in the relationship between Se
intake and health effects: factors that need
to be considered
Though the results of the Danish PRECISE trial show
excess mortality on long-term (5 year) exposure to
300 μg Se/day as Se yeast of a population experiencing
much lower Se exposure (plasma-Se concentration at
baseline, 89 μg/L, that rose to 284 μg/L after 5 years)
[20], it is notable that population groups with long-term
high-Se exposure appear to cope with a Se intake or status
of the same magnitude as in that trial without suffering
adverse effects, e.g. Inuit of Greenland and Northern
Canada, populations of the Brazilian Amazon, and some
local Chinese populations. There are a number of possible
reasons for this, as outlined below.
1. It appears that some people and/or populations are better
able to tolerate low or high Se intake than others owing to
the presence of polymorphisms (SNPs) in genes that af-
fect their ability to deal with a low or high Se intake. This
has been best demonstrated in relation to deficient intake.
The allele frequency of SNPs in several selenoprotein
genes changes in response to differences in environmental
Se [24], e.g. SNPs in:
(i) Selenoprotein genes, GPX1 , DIO2 , DIO3 ,
SELENOS, SELENOM
(ii) Genes involved in Se/Sec regulation of CELF1,
SPS2, SEPSECS, ELAVL1, Ser-tRNASec and
SELENOP
(iii) Genes involved in excretion/detoxification of Se,
s u c h a s I NM T ( i n d o l e t h y l a m i n e N -
methyltransferase).
In relation to the third point, Se is excreted by being me-
tabolized to methylated Se products in breath or urine and to
urinary selenosugars [25]. Individuals with the AA or AG
INMT genotype can metabolize Se to trimethyl-selenonium
ion (TMSe) in the urine, thereby excreting more Se and po-
tentially reducing toxicity [26]. The frequency of TMSe pro-
duction varies markedly between populations and individuals
[26].
2. High Se status, with apparent absence of toxicity and even
beneficial health effects, can be found in populations ex-
posed to toxic elements, such as arsenic, cadmium and
mercury, all of which are known to interact with Se.
Sequestration in inert conjugates that can be excreted
has been suggested as accounting for this. Various struc-
tures have been proposed for a complex between mercury
and selenium or selenoprotein P (SELENOP), such as
MeHg-Se-SELENOP [27] and (Hg-Se)n]m-SELENOP
[28]. A complex of arsenic and Se [(GS)2AsSe] has been
detected in rabbits [29] while a cadmium-Se complex
with a molar ratio of 1:1 which was able to bind to
SELENOP, has been shown to form in vitro [30].
(i) High mercury content is found in the diet of the Inuit
in Greenland and Nunavik (Northern Quebec) as a
result of consumption of top predator marine mam-
mals and fish [31]. In a study of 852 Inuit adults who
participated in the 2004 Nunavik Inuit Health Survey,
up to 50% of plasma mercury was associated with
SELENOP [32]. In the International Polar Year
Inuit Health Survey (IHS) of Inuit in Canada con-
ducted in 2007 and 2008, geometric mean blood Se
and total Hg were 319.5 μg/L and 7.0 μg/L, respec-
tively [33]. High Se exposure was shown to lower the
Fig. 2 U-shaped relationship
between Se status and disease risk
(for references, see [3])
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odds ratios for hypertension, stroke, and myocardial
infarction associated with mercury exposure [33]. In
the same study, participants with stroke had lower
blood Se (geometric mean: 260 μg/L vs. 319 μg/L)
and dietary Se (144 μg/day vs. 190 μg/day) than
individuals without stroke [34].
High levels of dietary mercury are also found in the
Brazilian Amazon, notably in communities of the Tapajós
River [mean intake (SD) 0.92 (0.89) μg/kg/day] [35]. The
dietary Se intake in these villages ranges from normal to very
high owing to the consumption of large amounts of Brazil
nuts, chicken, game and certain fish species [36]. In partici-
pants recruited from 12 communities along the Tapajós River,
median blood and plasma Se were 228 (range 103–1500)
μg/L and 135 (range 54–913) μg/L, respectively [36].
Although blood and plasma concentrations exceeded concen-
trations considered toxic [blood Se: 1000 μg/L (US EPA
2002)], no signs of Se toxicity (dermal or breath) or sentinel
symptoms (gastrointestinal disorders and motor/sensory defi-
cits) were found, despite very high Se status in some individ-
uals [36]. Interestingly, only three of 407 participants reported
diabetes.
(ii) Rice easily takes up arsenic and elevated exposure is
frequent in areas of Bangladesh, India, China and
Thailand [37]. An antagonistic relationship between Se
and arsenic was first observed in 1938 when it was dis-
covered that Se-poisoned rats could be treated with arse-
nic [38]. Antagonism between arsenic and Se, whereby
each reduces the toxicity of the other, has been well
documented in animal models [39].
(iii) Cadmium, a potent pro-oxidant, accumulates in the kid-
ney, increasing oxidative stress [40]; the demand for Se
in the kidney may increase with higher cadmium
exposure, as Se is required for the expression of the
antioxidant enzyme, GPX3, which is produced in the
kidney [41]. High cadmium was found in the Enshi area
of China known for Se intake in the toxic range [42].
3. Beneficial and harmful effects of Se depend on Se dose
and form (speciation) (see Fig. 3). It has been proposed
that Se may have hermetic effects, i.e. a biphasic dose
response to an agent characterized by a beneficial effect
at a low dose and an inhibitory or toxic effect at a high
dose [43]; this can be represented by the U-shaped re-
sponse to increasing Se intake/status, as observed.
While selenoproteins are generally considered to have
beneficial health effects, there are selenoproteins with par-
adoxical roles with potentially harmful outcomes [43],
e.g. GPX1, implicated in insulin resistance [44] and
SELENOP, associated with type 2 diabetes [45].
In relation to Se dose, as Se intake increases, particu-
larly if the main source is selenomethionine (SeMet) or Se
yeast (60% of which is SeMet [46]), SeMet will increas-
ingly replace methionine in body proteins, where its turn-
over is exceptionally slow (whole-body turn-over time,
363 days) [47]. Of course, SeMet can also be metabolized
to selenide , whereby i t can act as a source of
selenoproteins. However, SeMet has toxic effects that
are mediated by metabolism to selenols/selenolates that
can redox-cycle, generate superoxide radicals, and react
with thiols/diselenides to produce selenyl sulphides/
disulphides [20]. The latter can cause protein aggregation,
inactivation of transcription factors, disruption of redox-
regulated cell signaling, and endoplasmic reticulum (ER)
stress [20]. It should be noted that Se, as sodium selenite,
would be metabolized to hydrogen selenide, used for the
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Fig. 3 Beneficial and harmful effects of Se depending on dose and form
(speciation). It is proposed that Se has hermetic effects, shown by the blue
line [43]. Selenoproteins with beneficial health effects are shown as a
green line, while selenoproteins with paradoxical roles that appear to
have harmful effects are shown as a red line [43–45]. As Se intake
increases, particularly if the main source is SeMet, SeMet will
increasingly replace methionine in body proteins, where its turnover is
exceptionally slow; SeMet has toxic effects that are explained in the text
(figure created with assistance fromWen-Hsing Cheng, Mississippi State
University, Mississippi State, USA)
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generation of selenoproteins or excreted, and would not
build up in the body in the same way as SeMet [48].
4. About one quarter of all bacteria express selenoproteins
and therefore require Se for optimal growth [49]. Gut
microorganisms are sensitive to trace elements and some
require Se for normal metabolic functions [49]. In metab-
olizing Se, they produce volatile methylated Se com-
pounds, such as dimethyldiselenide from SeMet, in the
intestinal tract that are excreted, thus protecting the host
from toxicity due to high Se exposure [50]. It is possible
that exposure to high Se intake from birth or from a very
young age alters the composition of the gut microbiota in
such a way that excess Se is more readily excreted. Of
course, this use of Se by microorganisms decreases the
avai labi l i ty of Se for the expression of host
selenoproteins, resulting in increased requirement of the
host for Se [49].
Conclusion
The concept of the U-shaped relationship between Se intake/
status and its health effects, while useful, is clearly somewhat
simplistic. We need a better understanding of the subtle factors
outlined above that affect the Se requirements for optimal
health, which vary by population and, indeed, between indi-
viduals. It would be interesting, for instance, to investigate
whether the gut microbiome differs significantly in high vs.
moderate consumers of Se. Se will still keep us guessing for
some time to come.
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